image
Industrials - Specialty Business Services - NYSE - US
$ 67.34
-1.91 %
$ 3.81 B
Market Cap
14.51
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one MMS stock under the worst case scenario is HIDDEN Compared to the current market price of 67.3 USD, Maximus, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one MMS stock under the base case scenario is HIDDEN Compared to the current market price of 67.3 USD, Maximus, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one MMS stock under the best case scenario is HIDDEN Compared to the current market price of 67.3 USD, Maximus, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart MMS

image
$95.0$95.0$90.0$90.0$85.0$85.0$80.0$80.0$75.0$75.0$70.0$70.0$65.0$65.0$60.0$60.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
5.31 B REVENUE
8.19%
488 M OPERATING INCOME
65.71%
307 M NET INCOME
89.70%
515 M OPERATING CASH FLOW
63.92%
-129 M INVESTING CASH FLOW
-59.46%
-276 M FINANCING CASH FLOW
-9.91%
1.4 B REVENUE
6.60%
86.8 M OPERATING INCOME
-22.34%
41.2 M NET INCOME
-43.18%
-80 M OPERATING CASH FLOW
-48.83%
-22.3 M INVESTING CASH FLOW
30.32%
-8.26 M FINANCING CASH FLOW
81.98%
Balance Sheet Maximus, Inc.
image
Current Assets 1.2 B
Cash & Short-Term Investments 183 M
Receivables 880 M
Other Current Assets 138 M
Non-Current Assets 2.93 B
Long-Term Investments 0
PP&E 220 M
Other Non-Current Assets 2.71 B
4.43 %21.29 %3.34 %5.33 %65.61 %Total Assets$4.1b
Current Liabilities 808 M
Accounts Payable 303 M
Short-Term Debt 40.1 M
Other Current Liabilities 464 M
Non-Current Liabilities 1.48 B
Long-Term Debt 97.2 M
Other Non-Current Liabilities 1.38 B
13.25 %20.28 %4.25 %60.47 %Total Liabilities$2.3b
EFFICIENCY
Earnings Waterfall Maximus, Inc.
image
Revenue 5.31 B
Cost Of Revenue 4.05 B
Gross Profit 1.25 B
Operating Expenses 763 M
Operating Income 488 M
Other Expenses 182 M
Net Income 307 M
6b6b5b5b4b4b3b3b2b2b1b1b005b(4b)1b(763m)488m(182m)307mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
23.59% GROSS MARGIN
23.59%
9.21% OPERATING MARGIN
9.21%
5.78% NET MARGIN
5.78%
16.65% ROE
16.65%
7.43% ROA
7.43%
10.96% ROIC
10.96%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Maximus, Inc.
image
500m500m450m450m400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 307 M
Depreciation & Amortization 126 M
Capital Expenditures -114 M
Stock-Based Compensation 35.3 M
Change in Working Capital 78.9 M
Others 116 M
Free Cash Flow 401 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Maximus, Inc.
image
Wall Street analysts predict an average 1-year price target for MMS of $110 , with forecasts ranging from a low of $110 to a high of $110 .
MMS Lowest Price Target Wall Street Target
110 USD 63.35%
MMS Average Price Target Wall Street Target
110 USD 63.35%
MMS Highest Price Target Wall Street Target
110 USD 63.35%
Price
Max Price Target
Min Price Target
Average Price Target
11011010510510010095959090858580807575707065656060May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.41% DIVIDEND YIELD
0.3 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.2001.2001.0001.0000.8000.8000.6000.6000.4000.4000.2000.2000.0000.0000.0450.0450.0450.0450.250.280.280.280.280.30.30.0450.0450.0450.0450.250.280.280.280.280.30.0450.0450.0450.0450.0450.250.280.280.280.280.30.0450.180.0450.180.0450.180.0450.180.250.800.281.090.281.120.281.120.281.120.31.180.30.902015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 7
6. Ownership
Insider Ownership Maximus, Inc.
image
Sold
0-3 MONTHS
1.15 M USD 2
3-6 MONTHS
163 K USD 1
6-9 MONTHS
126 K USD 1
9-12 MONTHS
0 USD 0
Bought
6.64 K USD 2
0-3 MONTHS
754 K USD 5
3-6 MONTHS
6.59 K USD 2
6-9 MONTHS
6.57 K USD 2
9-12 MONTHS
7. News
Maximus Benefits From Buyouts & Strong Cash Flow From Operations The MMS stock is improving on the back of a strong operating cash flow, providing it with a competitive edge. zacks.com - 2 weeks ago
Is Maximus (MMS) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 2 weeks ago
Maximus Total Experience Management (TXM) Adds Salesforce's Agentforce to Transform Customer Experience for Government TYSONS, Va.--(BUSINESS WIRE)--Maximus announces new technology partnership with Salesforce. businesswire.com - 3 weeks ago
Should Value Investors Buy Maximus (MMS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 1 month ago
Here's Why You Should Add Maximus Stock to Your Portfolio Now MMS maintains solid relationships and a strong reputation with governments. zacks.com - 1 month ago
Maximus (MMS) Upgraded to Strong Buy: Here's Why Maximus (MMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com - 1 month ago
Best Value Stocks to Buy for March 4th MMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 4, 2025. zacks.com - 1 month ago
After Plunging -13.4% in 4 Weeks, Here's Why the Trend Might Reverse for Maximus (MMS) The heavy selling pressure might have exhausted for Maximus (MMS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. zacks.com - 1 month ago
Are Investors Undervaluing Maximus (MMS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 1 month ago
Maximus' Q1 Earnings & Revenues Beat Estimates, Increase Y/Y MMS' first-quarter fiscal 2025 revenues and earnings rise 20.2% and 5.7% on a year-over-year basis. zacks.com - 2 months ago
Maximus, Inc. (MMS) Q1 2025 Earnings Call Transcript Maximus, Inc. (NYSE:MMS ) Q1 2025 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Jessica Batt - Vice President of Investor Relations and ESG Bruce Caswell - President and Chief Executive Officer David Mutryn - Chief Financial Officer and Treasurer Conference Call Participants Charlie Strauzer - CJS Securities Brian Gesuale - Raymond James Operator Greetings and welcome to the Maximus Fiscal 2025 First Quarter Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 2 months ago
Maximus (MMS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Maximus (MMS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 2 months ago
8. Profile Summary

Maximus, Inc. MMS

image
COUNTRY US
INDUSTRY Specialty Business Services
MARKET CAP $ 3.81 B
Dividend Yield 0.41%
Description Maximus, Inc. provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S. state and local government programs, including the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, child support programs, Preadmission Screening and Resident Reviews, and Independent Developmental Disability assessments. This segment also provides program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; person-centered independent disability, long-term sick, and other health assessments; and specialized consulting services. The U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen support, and consumer education; independent medical reviews and worker's compensation benefit appeals; Medicare and Medicaid appeals; and federal marketplace eligibility appeals. This segment also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The Outside the U.S. segment offers BPS solutions for governments and commercial clients outside the United States, including health and disability assessments, program administration for employment services, and other job seeker-related services. The company was incorporated in 1975 and is headquartered in Tysons, Virginia.
Contact 1600 Tysons Boulevard, Tysons, VA, 22102 https://www.maximus.com
IPO Date June 13, 1997
Employees 41100
Officers Mr. David W. Mutryn CPA Chief Financial Officer & Treasurer Mr. John T. Martinez General Counsel, Chief Legal Officer & Corporate Secretary Ms. Ilene R. Baylinson General Manager of Health Services U.S. Ms. Theresa D. Golinvaux Principal Accounting Officer, Senior Vice President & Corporate Controller Mr. Jericho Seguin Senior Vice President of Corporate Development & Strategic Planning Mr. Bruce L. Caswell President, Chief Executive Officer & Director Mr. Derrick Pledger Chief Digital & Information Officer (CDIO) Ms. Eileen Cassidy Rivera Vice President of Communications & Public Relations Ms. Michelle F. Link Chief Human Resources Officer Mr. Mike Raker Chief Technology Officer